Article Details
Retrieved on: 2021-05-10 11:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here